• SENSEX
    NIFTY 50

Bharat Biotech's Covaxin led to 'enhanced immune responses' in phase 1 trials, says Lancet

Updated : January 22, 2021 04:06 PM IST

The report was an interim one and does not determine the long-term safety outcomes or efficacy of the vaccine
On January 3, Covaxin became the country’s first indigenously produced vaccine against COVID-19 to get ‘restricted emergency approval’.
Bharat Biotech's Covaxin led to 'enhanced immune responses' in phase 1 trials, says Lancet
Published : January 22, 2021 04:06 PM IST

You May Also Like

Live TV

recommended for you

Advertisement